137 related articles for article (PubMed ID: 32512705)
1. G9a Is SETting the Stage for Colorectal Oncogenesis.
Bergin CJ; Benoit YD
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32512705
[TBL] [Abstract][Full Text] [Related]
2. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
Bergin CJ; Zouggar A; Haebe JR; Masibag AN; Desrochers FM; Reilley SY; Agrawal G; Benoit YD
Oncogene; 2021 Feb; 40(6):1191-1202. PubMed ID: 33323965
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis.
Kato S; Weng QY; Insco ML; Chen KY; Muralidhar S; Pozniak J; Diaz JMS; Drier Y; Nguyen N; Lo JA; van Rooijen E; Kemeny LV; Zhan Y; Feng Y; Silkworth W; Powell CT; Liau BB; Xiong Y; Jin J; Newton-Bishop J; Zon LI; Bernstein BE; Fisher DE
Cancer Discov; 2020 Jul; 10(7):980-997. PubMed ID: 32269030
[TBL] [Abstract][Full Text] [Related]
4. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
5. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
[TBL] [Abstract][Full Text] [Related]
6. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
[TBL] [Abstract][Full Text] [Related]
7. G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.
Cha ST; Tan CT; Chang CC; Chu CY; Lee WJ; Lin BZ; Lin MT; Kuo ML
Nat Cell Biol; 2016 Sep; 18(9):993-1005. PubMed ID: 27525719
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation.
Zhang J; He P; Xi Y; Geng M; Chen Y; Ding J
Oncotarget; 2015 Feb; 6(5):2917-27. PubMed ID: 25595900
[TBL] [Abstract][Full Text] [Related]
9. Regulation of
Dobson THW; Hatcher RJ; Swaminathan J; Das CM; Shaik S; Tao RH; Milite C; Castellano S; Taylor PH; Sbardella G; Gopalakrishnan V
Mol Cancer Res; 2017 Aug; 15(8):1073-1084. PubMed ID: 28483947
[TBL] [Abstract][Full Text] [Related]
10. MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis.
Tu WB; Shiah YJ; Lourenco C; Mullen PJ; Dingar D; Redel C; Tamachi A; Ba-Alawi W; Aman A; Al-Awar R; Cescon DW; Haibe-Kains B; Arrowsmith CH; Raught B; Boutros PC; Penn LZ
Cancer Cell; 2018 Oct; 34(4):579-595.e8. PubMed ID: 30300580
[TBL] [Abstract][Full Text] [Related]
11. Low G9a expression is a tumor progression factor of colorectal cancer via IL-8 promotion.
Ichikawa Y; Takahashi H; Chinen Y; Arita A; Sekido Y; Hata T; Ogino T; Miyoshi N; Uemura M; Yamamoto H; Mizushima T; Doki Y; Eguchi H
Carcinogenesis; 2022 Sep; 43(8):797-807. PubMed ID: 35640269
[TBL] [Abstract][Full Text] [Related]
12. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling.
Li J; Yu B; Deng P; Cheng Y; Yu Y; Kevork K; Ramadoss S; Ding X; Li X; Wang CY
Nat Commun; 2017 Apr; 8():15146. PubMed ID: 28440295
[TBL] [Abstract][Full Text] [Related]
13. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
14. G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation.
Pan MR; Hsu MC; Chen LT; Hung WC
Sci Rep; 2015 Dec; 5():18709. PubMed ID: 26688070
[TBL] [Abstract][Full Text] [Related]
15. G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of
Zhang J; Wang Y; Shen Y; He P; Ding J; Chen Y
Theranostics; 2018; 8(10):2884-2895. PubMed ID: 29774081
[No Abstract] [Full Text] [Related]
16. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
Lin X; Huang Y; Zou Y; Chen X; Ma X
Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
[TBL] [Abstract][Full Text] [Related]
17. Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression.
Chang CC; Wu MJ; Yang JY; Camarillo IG; Chang CJ
Cancer Res; 2015 Jun; 75(11):2375-2386. PubMed ID: 25840984
[TBL] [Abstract][Full Text] [Related]
18. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
[TBL] [Abstract][Full Text] [Related]
19. G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin.
Wang YF; Zhang J; Su Y; Shen YY; Jiang DX; Hou YY; Geng MY; Ding J; Chen Y
Nat Commun; 2017 Aug; 8(1):274. PubMed ID: 28819251
[TBL] [Abstract][Full Text] [Related]
20. Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.
Liu CW; Hua KT; Li KC; Kao HF; Hong RL; Ko JY; Hsiao M; Kuo ML; Tan CT
Mol Cancer Ther; 2017 Jul; 16(7):1421-1434. PubMed ID: 28265008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
